Search

Your search keyword '"Brain Neoplasms pathology"' showing total 43,009 results

Search Constraints

Start Over You searched for: Descriptor "Brain Neoplasms pathology" Remove constraint Descriptor: "Brain Neoplasms pathology"
43,009 results on '"Brain Neoplasms pathology"'

Search Results

1. Glioma immune microenvironment composition calculator (GIMiCC): a method of estimating the proportions of eighteen cell types from DNA methylation microarray data.

2. Brain tumor classification utilizing pixel distribution and spatial dependencies higher-order statistical measurements through explainable ML models.

3. Functional and oncological outcomes following more than three consecutive surgical resections for multiple relapses of initially grade 2 IDH-mutated gliomas.

4. MiR-124-3p inhibits cell stemness in glioblastoma via targeting EPHA2 through ALKBH5-mediated m6A modification.

5. Green-synthesis of silver nanoparticles AgNPs from Podocarpus macrophyllus for targeting GBM and LGG brain cancers via NOTCH2 gene interactions.

6. Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis.

7. One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma.

8. The self-organized structure of glioma oncostreams and the disruptive role of passive cells.

9. Deep learning-based super-resolution and denoising algorithm improves reliability of dynamic contrast-enhanced MRI in diffuse glioma.

10. Machine learning-based new classification for immune infiltration of gliomas.

11. A novel scoring system proposal to guide surgical treatment indications for high grade gliomas in elderly patients: DAK-75.

12. Transcription factor YY1-activated GNG5 facilitates glioblastoma cell growth, invasion, stemness and glycolysis through Wnt/β-catenin pathway.

13. Prognosis prediction via histological evaluation of cellular heterogeneity in glioblastoma.

14. Blood-Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy.

15. Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy.

16. Targeted Microglial Membrane-Coated MicroRNA Nanosponge Mediates Inhibition of Glioblastoma.

17. HSV-1-induced N6-methyladenosine reprogramming via ICP0-mediated suppression of METTL14 potentiates oncolytic activity in glioma.

18. IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma.

19. Doxorubicin-Loaded Ultrasmall Gold Nanoparticles (1.5 nm) for Brain Tumor Therapy and Assessment of Their Biodistribution.

20. Efficacy of various extent of resection on survival rates of patients with pilocytic astrocytoma: based on a large population.

21. Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas.

22. The Large GTPase Guanylate-Binding Protein-1 (GBP-1) Promotes Mitochondrial Fission in Glioblastoma.

23. Synthesis, Cytotoxicity, and Mechanistic Evaluation of Tetrahydrocurcumin-Amino Acid Conjugates as LAT1-Targeting Anticancer Agents in C6 Glioma Cells.

24. Status Quo in the Liposome-Based Therapeutic Strategies Against Glioblastoma: "Targeting the Tumor and Tumor Microenvironment".

25. Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy.

26. Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood-Brain Barrier and Treat Murine Glioma.

27. Bioinformatics investigation of the prognostic value and mechanistic role of CD9 in glioma.

28. MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genes.

29. Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma.

30. Pathomics models for CD40LG expression and prognosis prediction in glioblastoma.

31. Central nervous system solitary fibrous tumors: Case series in accordance with the WHO 2021 reclassification. Framework for patient surveillance.

32. Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management.

33. De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.

34. Titanium boride nanosheets with photo-enhanced sonodynamic efficiency for glioblastoma treatment.

35. Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma.

36. Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome.

37. Blood transfusion in pediatric intracranial tumor surgery.

38. Spark in the darkness: Discovering action potentials in brain tumors.

39. Architecture sets the path: Breast cancer subtypes differently shape the early brain metastatic niche.

40. Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain.

41. Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma.

42. Integrated electrophysiological and genomic profiles of single cells reveal spiking tumor cells in human glioma.

43. Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.

44. "Navigating the complexities of low-Grade glioma treatment: insights into SBT I-125 and novel assessment tools".

45. High-Grade Thalamic Glioma: Case Report with Literature Review.

48. Integrated bioinformatics analysis and experimental validation on malignant progression and immune cell infiltration of LTBP2 in gliomas.

49. Spatiotemporal modeling reveals high-resolution invasion states in glioblastoma.

50. Integrative multi-omics analysis unveils the connection between transcriptomic characteristics associated with mitochondria and the tumor immune microenvironment in lower-grade gliomas.

Catalog

Books, media, physical & digital resources